Management of COPD Exacerbations

Initial Management

The American Family Physician recommends initiating systemic corticosteroids (oral prednisolone 30-40 mg daily for 5-7 days) and antibiotics if at least two cardinal symptoms are present (increased dyspnea, increased sputum volume, purulent sputum) 1, 3
Obtain arterial blood gas analysis, chest radiograph, complete blood count, electrolytes, and ECG for all patients presenting with COPD exacerbation 3
Record initial FEV1 and/or peak flow when feasible 3
Send sputum for culture if purulent; consider blood cultures if pneumonia is suspected 3
Assess for life-threatening features: altered mental status, severe hypoxemia (PaO2 <50 mmHg), respiratory acidosis (pH <7.35), or hemodynamic instability requiring ICU admission 3

Target oxygen saturation of 88-92% to correct hypoxemia while avoiding CO2 retention 3
Initially use controlled oxygen delivery via Venturi mask (FiO2 ≤28%) or nasal cannula (≤2 L/min) until arterial blood gases are known 3
Recheck arterial blood gases within 60 minutes of starting oxygen and after any change in inspired oxygen concentration 3
Critical pitfall: Avoid high-flow oxygen in COPD patients as this can worsen hypercapnia and precipitate respiratory failure 3

Administer nebulized bronchodilators immediately upon arrival and continue at 4-6 hour intervals 3
For moderate exacerbations, use either a beta-agonist or anticholinergic 3
For severe exacerbations, use both beta-agonist and anticholinergic combination therapy 3
Short-acting bronchodilators remain first-line treatment during acute exacerbations 3

Administer oral prednisolone 30-40 mg daily for 5-7 days for all COPD exacerbations requiring medical attention 4, 3
Oral and intravenous routes are equally effective; use oral unless patient cannot tolerate oral intake 4
Discontinue corticosteroids after 5-7 days unless specifically indicated for long-term treatment 3
Systemic corticosteroids improve lung function, oxygenation, shorten recovery time, and reduce hospitalization duration 3
Critical pitfall: Avoid prolonged courses beyond 7-14 days due to increased adverse effects without additional benefit 3

Prescribe antibiotics when patients present with at least two of three cardinal symptoms: increased dyspnea, increased sputum volume, and purulent sputum 1, 3
Antibiotics reduce short-term mortality by 77%, treatment failure by 53%, and sputum purulence by 44% 3
First-line options: amoxicillin or tetracycline 3
Second-line options: broad-spectrum cephalosporins or newer macrolides 3
Tailor antibiotic selection based on local resistance patterns and patient risk factors 3

Initiate NIV as first-line ventilatory support for patients with acute or acute-on-chronic respiratory failure 4, 3
Specific indications for NIV: persistent hypoxemia despite supplemental oxygen, respiratory acidosis (pH <7.35), or severe dyspnea with signs of respiratory muscle fatigue 3
NIV reduces mortality and intubation rates by 80-85% in appropriate patients 3
Consider invasive mechanical ventilation if NIV fails 3

Arrange follow-up within 30 days after discharge to review discharge therapy and make necessary adjustments 3
Schedule additional follow-up at 3 months to ensure return to stable state 3
Initiate early pulmonary rehabilitation within 3 weeks after hospital discharge to improve exercise capacity, reduce healthcare costs, and decrease future exacerbation rates 4, 3